檢索結果 - Rachel M. Squillace

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    α7 Integrin Mediates Cell Adhesion and Migration on Specific Laminin Isoforms

    α7 Integrin Mediates Cell Adhesion and Migration on Specific Laminin Isoforms 由 Chung‐Chen Jane Yao, Barry L. Ziober, Rachel M. Squillace, Randall H. Kramer

    出版 1996
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    mTOR-Raptor Binds and Activates SGK1 to Regulate p27 Phosphorylation

    mTOR-Raptor Binds and Activates SGK1 to Regulate p27 Phosphorylation 由 Feng Hong, Michelle D. Larrea, Cheryl A. Doughty, David J. Kwiatkowski, Rachel M. Squillace, Joyce M. Slingerland

    出版 2008
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Insulin Stimulates Adipogenesis through the Akt-TSC2-mTORC1 Pathway

    Insulin Stimulates Adipogenesis through the Akt-TSC2-mTORC1 Pathway 由 Huihui Zhang, Jingxiang Huang, Katrin Düvel, Bernard Boback, Shulin Wu, Rachel M. Squillace, Chin‐Lee Wu, Brendan D. Manning

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    The evolutionarily conserved TSC/Rheb pathway activates Notch in tuberous sclerosis complex and Drosophila external sensory organ development

    The evolutionarily conserved TSC/Rheb pathway activates Notch in tuberous sclerosis complex and Drosophila external sensory organ development 由 Magdalena Karbowniczek, Diana Zitserman, Damir Khabibullin, Tiffiney R. Hartman, Jane Yu, Tasha Morrison, Émmanuelle Nicolas, Rachel M. Squillace, Fabrice Roegiers, Elizabeth P. Henske

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Rapamycin-Insensitive Up-Regulation of <i>MMP2</i> and Other Genes in Tuberous Sclerosis Complex 2–Deficient Lymphangioleiomyomatosis-Like Cells

    Rapamycin-Insensitive Up-Regulation of <i>MMP2</i> and Other Genes in Tuberous Sclerosis Complex 2–Deficient Lymphangioleiomyomatosis-Like Cells 由 Po‐Shun Lee, Szeman W. Tsang, Marsha A. Moses, Zachary Trayes-Gibson, Li‐Li Hsiao, Roderick V. Jensen, Rachel M. Squillace, David J. Kwiatkowski

    出版 2009
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Ridaforolimus (AP23573; MK-8669), a Potent mTOR Inhibitor, Has Broad Antitumor Activity and Can Be Optimally Administered Using Intermittent Dosing Regimens

    Ridaforolimus (AP23573; MK-8669), a Potent mTOR Inhibitor, Has Broad Antitumor Activity and Can Be Optimally Administered Using Intermittent Dosing Regimens 由 Victor M. Rivera, Rachel M. Squillace, David F. Miller, Lori Berk, Scott Wardwell, Yaoyu Ning, Roy M. Pollock, Narayana I. Narasimhan, John D. Iuliucci, Frank Wang, Tim Clackson

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Redox Proteomics Analyses of the Influence of Co-Expression of Wild-Type or Mutated LRRK2 and Tau on <i>C. elegans</i> Protein Expression and Oxidative Modification: Relevance to Parkinson Disease

    Redox Proteomics Analyses of the Influence of Co-Expression of Wild-Type or Mutated LRRK2 and Tau on <i>C. elegans</i> Protein Expression and Oxidative Modification: Relevance to P... 由 Fabio Di Domenico, Rukhsana Sultana, Andrew Ferree, Katelyn Smith, Eugenio Barone, Marzia Perluigi, Raffaella Coccia, William M. Pierce, Jian Cai, Cesare Mancuso, Rachel M. Squillace, Manfred Wiengele, Isabella Dalle‐Donne, Benjamin Wolozin, D. Allan Butterfield

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations

    Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations 由 Siraj M. Ali, Sumanta K. Pal, Kai Wang, Norma Alonzo Palma, Eric M. Sanford, Mark Bailey, Jie He, Julia A. Elvin, Juliann Chmielecki, Rachel M. Squillace, Edward Dow, Deborah Morosini, Jamie Buell, Roman Yelensky, Doron Lipson, Garrett M. Frampton, Peter M. Howley, Jeffrey S. Ross, Philip J. Stephens, Vincent A. Miller

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in Preclinical Models

    The Potent ALK Inhibitor Brigatinib (AP26113) Overcomes Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in Preclinical Models 由 Sen Zhang, Rana Anjum, Rachel M. Squillace, Sara Nadworny, Tianjun Zhou, Jeff Keats, Yaoyu Ning, Scott Wardwell, David F. Miller, Youngchul Song, Lindsey Eichinger, Lauren Moran, Wei‐Sheng Huang, Shuangying Liu, Dong Zou, Yihan Wang, Qurish K. Mohemmad, Hyun Gyung Jang, Emily Ye, Narayana I. Narasimhan, Frank Wang, Juan J. Miret, Xiaotian Zhu, Tim Clackson, David C. Dalgarno, William C. Shakespeare, Victor M. Rivera

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: